US Stock MarketDetailed Quotes

BIOR Biora Therapeutics

Watchlist

0.6100
-0.0099-1.60%

Trading Apr 25 12:05 ET

21.89MMarket Cap-77P/E (TTM)

Biora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

-98.69%4K

-98.08%2K

-98.13%2K

-75.54%305K

-96.78%14K

-56.04%80K

-77.54%104K

-35.93%107K

Operating revenue

-98.69%4K

--0

-98.08%2K

-98.13%2K

-75.54%305K

-96.78%14K

-56.04%80K

-77.54%104K

-35.93%107K

Cost of revenue

Gross profit

Operating expense

8.15%67.15M

-3.23%13.34M

66.97%23.32M

4.35%14.94M

-22.33%15.55M

-47.86%62.09M

-33.04%13.79M

-54.57%13.97M

-60.37%14.31M

-36.72%20.02M

Selling and administrative expenses

-1.91%37.31M

-9.93%7.23M

56.79%12.77M

6.46%8.95M

-37.91%8.36M

-48.11%38.04M

-33.74%8.02M

-56.00%8.15M

-62.98%8.41M

-32.57%13.46M

-General and administrative expense

----

-37.91%8.36M

----

--13.46M

Research and development costs

24.07%29.84M

6.09%6.12M

81.22%10.55M

1.34%5.98M

9.64%7.19M

-47.47%24.05M

-32.03%5.77M

-52.40%5.82M

-55.94%5.9M

-43.82%6.56M

Operating profit

-8.68%-67.14M

3.14%-13.34M

-67.93%-23.32M

-5.10%-14.93M

21.92%-15.54M

47.57%-61.78M

31.66%-13.78M

54.56%-13.89M

60.14%-14.21M

36.73%-19.91M

Net non-operating interest income expense

10.69%-9.82M

31.47%-1.84M

6.53%-2.59M

2.49%-2.7M

2.90%-2.68M

13.03%-10.99M

-22.83%-2.69M

19.81%-2.77M

20.85%-2.77M

21.59%-2.76M

Non-operating interest expense

-10.69%9.82M

-31.47%1.84M

-6.53%2.59M

-2.49%2.7M

-2.90%2.68M

-13.03%10.99M

22.83%2.69M

-19.81%2.77M

-20.85%2.77M

--2.76M

Other net income (expense)

-301.80%-47.47M

-116.70%-543K

-2,545.47%-47.54M

-101.64%-166K

-90.43%783K

148.83%23.52M

105.37%3.25M

168.09%1.94M

552.03%10.15M

-53.33%8.18M

Gain on sale of security

-13.87%18M

133.29%12.73M

123.48%4.57M

-103.65%-161K

-90.39%864K

138.60%20.9M

111.29%5.46M

161.53%2.04M

185.76%4.41M

239.21%8.99M

Other non- operating income (expenses)

-2,601.72%-65.47M

-501.54%-13.28M

-52,008.00%-52.11M

-100.09%-5K

90.01%-81K

-56.31%2.62M

81.94%-2.21M

-121.41%-100K

97.69%5.74M

-105.45%-811K

Income before tax

-152.64%-124.42M

-19.05%-15.73M

-399.14%-73.45M

-160.51%-17.8M

-20.37%-17.44M

72.43%-49.25M

84.07%-13.21M

60.09%-14.72M

83.49%-6.83M

17.02%-14.49M

Income tax

78.57%-90K

-136.68%-95K

-99.37%1K

100.48%4K

-252.94%-420K

317.65%259K

158K

-837K

Net income

-225.27%-124.12M

-12.32%-15.41M

-1,336.33%-73.45M

-223.00%-17.81M

-26.31%-17.44M

84.58%-38.16M

85.22%-13.72M

88.31%-5.11M

92.98%-5.51M

57.20%-13.81M

Net income continuous Operations

-154.63%-124.33M

-16.06%-15.63M

-393.84%-73.45M

-196.93%-17.81M

-20.37%-17.44M

72.65%-48.83M

83.73%-13.47M

59.66%-14.87M

85.51%-6M

17.02%-14.49M

Net income discontinuous operations

-97.95%219K

186.56%219K

--0

115.49%10.67M

97.49%-253K

242.07%9.76M

101.30%484K

104.61%682K

Minority interest income

Net income attributable to the parent company

-225.27%-124.12M

-12.32%-15.41M

-1,336.33%-73.45M

-223.00%-17.81M

-26.31%-17.44M

84.58%-38.16M

85.22%-13.72M

88.31%-5.11M

92.98%-5.51M

57.20%-13.81M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-225.27%-124.12M

-12.32%-15.41M

-1,336.33%-73.45M

-223.00%-17.81M

-26.31%-17.44M

84.58%-38.16M

85.22%-13.72M

88.31%-5.11M

92.98%-5.51M

57.20%-13.81M

Basic earnings per share

93.70%-7.87

66.24%-0.5537

-619.12%-4.89

-96.00%-1.47

15.43%-1.59

-94.31%-125

88.29%-1.64

94.09%-0.68

97.56%-0.75

86.57%-1.88

Diluted earnings per share

93.70%-7.87

66.24%-0.5537

-619.12%-4.89

-96.00%-1.47

15.43%-1.59

-94.31%-125

88.29%-1.64

94.09%-0.68

97.56%-0.75

86.57%-1.88

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	-98.69%4K	0	0	-98.08%2K	-98.13%2K	-75.54%305K	-96.78%14K	-56.04%80K	-77.54%104K	-35.93%107K
Operating revenue	-98.69%4K	--0	--0	-98.08%2K	-98.13%2K	-75.54%305K	-96.78%14K	-56.04%80K	-77.54%104K	-35.93%107K
Cost of revenue
Gross profit
Operating expense	8.15%67.15M	-3.23%13.34M	66.97%23.32M	4.35%14.94M	-22.33%15.55M	-47.86%62.09M	-33.04%13.79M	-54.57%13.97M	-60.37%14.31M	-36.72%20.02M
Selling and administrative expenses	-1.91%37.31M	-9.93%7.23M	56.79%12.77M	6.46%8.95M	-37.91%8.36M	-48.11%38.04M	-33.74%8.02M	-56.00%8.15M	-62.98%8.41M	-32.57%13.46M
-General and administrative expense	----	----	----	----	-37.91%8.36M	----	----	----	----	--13.46M
Research and development costs	24.07%29.84M	6.09%6.12M	81.22%10.55M	1.34%5.98M	9.64%7.19M	-47.47%24.05M	-32.03%5.77M	-52.40%5.82M	-55.94%5.9M	-43.82%6.56M
Operating profit	-8.68%-67.14M	3.14%-13.34M	-67.93%-23.32M	-5.10%-14.93M	21.92%-15.54M	47.57%-61.78M	31.66%-13.78M	54.56%-13.89M	60.14%-14.21M	36.73%-19.91M
Net non-operating interest income expense	10.69%-9.82M	31.47%-1.84M	6.53%-2.59M	2.49%-2.7M	2.90%-2.68M	13.03%-10.99M	-22.83%-2.69M	19.81%-2.77M	20.85%-2.77M	21.59%-2.76M
Non-operating interest expense	-10.69%9.82M	-31.47%1.84M	-6.53%2.59M	-2.49%2.7M	-2.90%2.68M	-13.03%10.99M	22.83%2.69M	-19.81%2.77M	-20.85%2.77M	--2.76M
Other net income (expense)	-301.80%-47.47M	-116.70%-543K	-2,545.47%-47.54M	-101.64%-166K	-90.43%783K	148.83%23.52M	105.37%3.25M	168.09%1.94M	552.03%10.15M	-53.33%8.18M
Gain on sale of security	-13.87%18M	133.29%12.73M	123.48%4.57M	-103.65%-161K	-90.39%864K	138.60%20.9M	111.29%5.46M	161.53%2.04M	185.76%4.41M	239.21%8.99M
Other non- operating income (expenses)	-2,601.72%-65.47M	-501.54%-13.28M	-52,008.00%-52.11M	-100.09%-5K	90.01%-81K	-56.31%2.62M	81.94%-2.21M	-121.41%-100K	97.69%5.74M	-105.45%-811K
Income before tax	-152.64%-124.42M	-19.05%-15.73M	-399.14%-73.45M	-160.51%-17.8M	-20.37%-17.44M	72.43%-49.25M	84.07%-13.21M	60.09%-14.72M	83.49%-6.83M	17.02%-14.49M
Income tax	78.57%-90K	-136.68%-95K	-99.37%1K	100.48%4K		-252.94%-420K	317.65%259K	158K	-837K
Net income	-225.27%-124.12M	-12.32%-15.41M	-1,336.33%-73.45M	-223.00%-17.81M	-26.31%-17.44M	84.58%-38.16M	85.22%-13.72M	88.31%-5.11M	92.98%-5.51M	57.20%-13.81M
Net income continuous Operations	-154.63%-124.33M	-16.06%-15.63M	-393.84%-73.45M	-196.93%-17.81M	-20.37%-17.44M	72.65%-48.83M	83.73%-13.47M	59.66%-14.87M	85.51%-6M	17.02%-14.49M
Net income discontinuous operations	-97.95%219K	186.56%219K	--0	--0	--0	115.49%10.67M	97.49%-253K	242.07%9.76M	101.30%484K	104.61%682K
Minority interest income
Net income attributable to the parent company	-225.27%-124.12M	-12.32%-15.41M	-1,336.33%-73.45M	-223.00%-17.81M	-26.31%-17.44M	84.58%-38.16M	85.22%-13.72M	88.31%-5.11M	92.98%-5.51M	57.20%-13.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-225.27%-124.12M	-12.32%-15.41M	-1,336.33%-73.45M	-223.00%-17.81M	-26.31%-17.44M	84.58%-38.16M	85.22%-13.72M	88.31%-5.11M	92.98%-5.51M	57.20%-13.81M
Basic earnings per share	93.70%-7.87	66.24%-0.5537	-619.12%-4.89	-96.00%-1.47	15.43%-1.59	-94.31%-125	88.29%-1.64	94.09%-0.68	97.56%-0.75	86.57%-1.88
Diluted earnings per share	93.70%-7.87	66.24%-0.5537	-619.12%-4.89	-96.00%-1.47	15.43%-1.59	-94.31%-125	88.29%-1.64	94.09%-0.68	97.56%-0.75	86.57%-1.88
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall